High resolution non-invasive detection of a fetal microdeletion using the GCREM algorithm

Prenatal Diagnosis

Volumn 34, Issue 5, 2014, Pages 469-477

  Chu, Tianjiao ^a   Yeniterzi, Suveyda ^a   Rajkovic, Aleksandar ^a   Hogge, W Allen ^a   Dunkel, Mary ^a   Shaw, Patricia ^a   Bunce, Kimberly ^a   Peters, David G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FETAL MICRODELETION; GC CONTENT RANDOM EFFECT MODEL; GENE DELETION; GENETIC ALGORITHM; GENETIC DISORDER; HUMAN; KARYOTYPING; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ALGORITHM; ANEUPLOIDY; BLOOD; DNA SEQUENCE; FETUS; GENE DUPLICATION; PREGNANCY; PROCEDURES;

ALGORITHMS; ANEUPLOIDY; DNA; FEMALE; FETUS; GENE DUPLICATION; HUMANS; KARYOTYPING; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84898825126     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4331     Document Type: Article

References (27)

1. Hertling-Schaal E, Perrotin F, de Poncheville L, et al. Maternal anxiety induced by prenatal diagnostic techniques: detection and management. Gynecol Obstet Fertil 2001;29(6):440-6.
2. Hewison J, Nixon J, Fountain J, et al. Amniocentesis results: investigation of anxiety. The ARIA trial. Health Technol Assess 2006;10(50):iii, ix-x, 1-78.
3. Hewison J, Nixon J, Fountain J, et al. A randomised trial of two methods of issuing prenatal test results: the ARIA (Amniocentesis Results: Investigation of Anxiety) trial. BJOG 2007;114(4):462-8.
4. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110(3):687-94.
5. Odibo AO, Gray DL, Dicke JM, et al. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 2008;111(3):589-95.
6. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1-7.
7. Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986;1(8493):1287-93.
8. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119(5):890-901.
9. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204(3):205 e1-11.
10. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14(3):296-305.
11. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13(11):913-20.
12. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58(7):1148-51.
13. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365(19):1847-8.
14. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92(2):167-76.
15. Yu SC, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 2013;8(4):e60968.
16. Hillman SC, Pretlove S, Coomarasamy A, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011;37(1):6-14.
17. Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2012;32(10):976-85.
18. Klopocki E, Hennig BP, Dathe K, et al. Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 2010;86(3):434-9.
19. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105(42):16266-71.
20. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62(4):768-75.
21. Chiu RW, Cantor CR, Lo YM. Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009;25(7):324-31.
22. Chu T, Bunce K, Hogge WA, et al. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease. Bioinformatics 2009;25(10):1244-50.
23. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
24. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-45.
25. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105(51):20458-63.
26. Lupski JR, Stankiewicz P. Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 2005;1(6):e49.
27. Shaffer LG, Lupski JR. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 2000;34:297-329.